Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

hidrocodona Tag

04 Jun [125] ¿Los prescriptores pueden evitar su contribución a la enfermedad por uso de opioides?

Posted at 11:21h in Therapeutics Letter-ES 0 Comments
Share

Caso de la ilustración: un individuo de 21 años de edad fue sometido a cirugía con la expectativa de mejorar su enfermedad. Se le prescribió al alta un opioide a dosis estándar durante cinco días....

Read More

agentes antibacterianos agentes broncodilatadores agonistas beta adrenérgicos antagonistas de los receptores de angiotensina antagonistas dopaminérgicos antidepresivos análisis de costo-beneficio complicaciones del embarazo costos de medicamentos covid-19 dejar de fumar deprescribiendo desprescripción detección masiva dolor dolor crónico dolor neuropático educación del paciente efectos adversos Efectos Secundarios y Reacciones Adversas Relacionadas con los Medicamentos Efectos secundarios y reacciones adversas relacionados con los medicamentos efectos secundarios y reacciones adversas relacionados con medicamentos enfermedad pulmonar obstructiva crónica factores de riesgo fibrosis quística gabapentina IBP Inhibidores de la Bomba de Protones levonorgestrel manejo de terapia con medicamentos Nirmatrelvir nitrofurantoína opioides Paxlovid pregabalina revisión sistemática Ritonavir SARS-CoV-2 seguridad seguridad del paciente sobrediagnóstico tapentadol tramadol tromboembolia vacuna

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2022 Therapeutics Initiative | Terms & Policies